Ke
Pan
,
Soraya
Manaviazar§
and
Karl J.
Hale§
*
The School of Chemistry and Chemical Engineering, Queen's University Belfast, Stranmillis Road, Belfast BT9 5AG, UK. E-mail: k.hale120@btinternet.com
First published on 24th March 2025
In this paper, a new asymmetric total synthesis of optically pure (+)-trichostatin A (1a) is described via a route that utilises a Marshall chiral allenylzinc addition between 9 and 4-dimethylaminobenzaldehyde (10) and an O-depivaloylation at its early stages. O-Directed free radical hydrostannation of the resulting propargylic alcohol 15 with Ph3SnH/cat. Et3B/O2 in PhMe at rt thereafter provided the (Z)-α-triphenylstannylvinyltin 16 in 80–89% yield, with complete stereocontrol and very high α:
β regioselectivity (25
:
1). A stereoretentive I–Sn exchange reaction between 16 and I2 (1.4 equiv.) in CH2Cl2 (−78 °C to rt, 1 h) subsequently secured the vinyl iodide 18 in 84–96% yield. The latter was transformed into the enal 4 by successive TPAP/NMO (Ley–Griffith) oxidation and a high yielding (80%) Stille reaction between the α-iodo enal 20 and Me4Sn, catalysed by Pd(PPh3)4 in DMF at 60 °C, under the Baldwin–Lee conditions, which use CsF and CuI as promoters. A Wittig reaction between 4 and Ph3P
CHCO2Et (5), saponification, and DDQ oxidation next afforded (+)-trichostatic acid (22). Helquist's ethyl chloroformate mixed-anhydride/TBSONH2 coupling procedure (ref. 17e) thereafter secured (+)-trichostatin A (1a) in good yield. This new total synthesis of 1a is the first-ever successful application of the O-directed dialkylacetylene free radical hydrostannation with Ph3SnH/cat. Et3B/O2 in a dialkylaniline N-containing disubstituted alkynol system, and it now provides a convenient means of accessing many novel trichostatin analogues for future biological screening.
![]() | ||
Scheme 1 The rt O-directed free radical hydrostannylative synthesis of (Z)-trisubstituted alkenes with Ph3SnH/cat. Et3B. |
But that is not to say that the thermally-mediated Bu3SnH/AIBN counterpart4 of this reaction does not have an equally important role to play in synthesis, particularly where tandem radical cyclisation is a cardinal requirement, as in Alabugin's traceless polyaromatic ring construction reactions,5 where his team's powerful contributions have been particularly elegant, innovative and synthetically impactful. Those same studies5 have also provided profound computational and experimental insights into the detailed mechanistic workings of the free radical hydrostannation reaction of propargylically-oxygenated disubstituted acetylenes, and affirmed the entirely free radical O-directed mechanism proposed for this process.3,4a–c
The O-directed Ph3SnH/cat. Et3B variant1,2 of this reaction has now shown its versatility in a wide range of complex settings that have included total syntheses of the natural products (+)-pumiliotoxin B6 and (−)-(3R)-inthomycin C.7 A noteworthy double O-directed free radical hydrostannation has also been introduced for the simultaneous installation of two structurally distinct trisubstituted alkenes within target structures. Its synthetic utility was powerfully demonstrated by the fully stereocontrolled route that was developed to the C(7)–C(22)-sector of (+)-acutiphycin.8 The Furstner team has likewise elegantly employed an O-directed free radical hydrostannation with Ph3SnH, cat. AIBN and PhMe in their total synthesis of (+)-isomigrastatin.9 In each of these synthetic applications, I–SnPh3 exchange has played a central role in final trisubstituted alkene elaboration10 and, for the synthesis of all-carbon branched alkene structures, the CuI/CsF Baldwin–Lee11 and Farina Ph3As variants12 of the Stille reaction have both proven themselves immensely valuable.6–8,10 Other Pd(0)-mediated cross-coupling methods (e.g. Suzuki, Negishi, and Cuprate) and carbonylations have shown themselves to be equally applicable in this sphere.10
While there have now been many impressive displays of the utility of the rt Ph3SnH/cat. Et3B O-directed hydrostannation in synthesis,6–8,10 there remain some classes of alkynes on which this reaction has yet to be successfully applied. Prominent amongst these substrates are propargyloxy dialkylacetylenes with an unprotected amine functionality. These generally form a complex with the Et3B initiator, to prevent the O2-mediated SH2 radical initiation event from ever taking place. Although a stoichiometric excess of Et3B can sometimes allow radical initiation to occur, frequently the outcomes of these processes are disappointing.
Despite all of the past difficulties, we recently decided to investigate whether weakly basic amines, such as anilines, might prove compatible with the Ph3SnH/cat. Et3B O-directed hydrostannation method. In this paper, we now report that the 4-dimethylanilino functionality is indeed well tolerated in this process, as demonstrated by our new asymmetric total synthesis of (+)-trichostatin A, where this reaction protocol was very effectively deployed alongside a Marshall chiral allenylzinc addition process.13
We also document here, for the first time ever, the profound inhibitory effect that an allylic OPv group can have on the course of a Pd-catalysed cross-coupling of a vinyl iodide. The latter observation was made quite by chance, whilst we were attempting to apply such a coupling to a trisubstituted vinyl iodide with such a functionality. Given this synthetic impasse, we thought it important to record this difficulty here, to prevent others from becoming similarly ensnared in the future.
(+)-Trichostatin A (1a) is a highly potent, naturally-occurring, histone deacetylase (HDAC) inhibitor that has elicited considerable medicinal interest as a possible antifungal,14a anticancer,14b,c immunosuppressive,14d and anti-Duchenne muscular dystrophy drug,15 but its clinical use has so far been precluded by its remarkably short plasma half-life (<6.3 min at 80 mg kg−1)14c and its pronounced genotoxicity. It is widely thought that if these undesirable properties could somehow be ablated by careful structural modification, as was recently found for glycosylated (+)-trichostatin C (1b),16 and HDAC specificity could also be improved, such trichostatin analogues might potentially become useful new treatments for a host of diseases. It was with such pharmaceutical and synthetic objectives in mind that we first embarked on the development of a new improved total synthesis17 of (+)-trichostatin A (1a) (R = OH), for the purpose of providing novel C(4)-analogues17e for drug screening and X-ray crystallographic/NMR studies. It was hoped that such studies might provide useful new insights into how individual HDAC isozymes work, as well as new therapeutic drugs.
Accordingly, we duly formulated the retrosynthetic plan of Scheme 2 for the synthetic acquisition17 of (+)-(R)-trichostatin A (1a). Underpinning our approach would be the O-directed free radical hydrostannation of alkyne 8 with Ph3SnH/Et3B, which would be allied with an I–Sn exchange and a Stille cross-coupling with Me4Sn. An O-depivaloylation and an alcohol oxidation would thereafter procure 4. The latter would then be chain extended with the ylide 5, the C(1)-carboxyl subsequently unmasked, and the C(7)-ketone thereafter elaborated, prior to C(1)-oxyamidation with TBSONH2. An O-desilylation would then complete the synthesis of 1a.17 Alkyne 8 would itself be created through a new Marshall chiral allenylzinc addition between the known chiral allenylzinc 913 and 4-dimethylaminobenzaldehyde (10) under Pd(0)-catalysis.
In light of this setback, we decided to cleave the OPv group from 8 with i-Bu2AlH (2 equiv.) in CH2Cl2 at −78 °C. The reaction took 2 h to reach completion, affording the desired alkynol 15 in 83% yield after extractive work up and SiO2 flash chromatography. It was later found more convenient and higher yielding (96–98% yield) to use K2CO3 in MeOH to accomplish this transformation over 5 h at rt (Scheme 4). The resulting alkynol 15 was then subjected to O-directed hydrostannation with Ph3SnH (1.7 equiv.) and Et3B (0.1 equiv.) and O2 in PhMe (1 M in 15) for 19 h at rt. This afforded a 25:
1 mixture of α
:
β vinyltriphenylstannanes 16 and 17, from which the two α-stannylated C(5)-diastereomers 16 could typically be purified with 80–89% yield after SiO2 flash chromatography.
Now that the Pv protecting group had been detached, the requisite I–Sn exchange reaction proceeded successfully with 16 to give 18 in >90% yield using only 1.4 equiv. of I2. This result provided good confirmatory evidence that the OPv group had been adversely involved in strong internal O-coordination to the metal centre in both 7 and 13, and our combined findings now pointed to a new strategic way forward.
The iodo-allylic alcohol 18 was next subjected to a Baldwin–Lee Stille cross-coupling with Me4Sn.11 It provided 19 efficiently in 80% yield after 22 h at rt. Importantly, this reaction had to be performed in complete darkness, inside a sealed vessel under N2, to prevent light-induced vinyl iodide decomposition. Notwithstanding this success, difficulties soon arose when attempts were made to oxidise alcohol 19 under Swern, PCC, or MnO2 oxidation conditions, due to the presence of the dimethylamino group. Only cat. TPAP/NMO19 afforded the desired enal 4, but in a disappointing 20% yield.
Even so, this positive outcome did prompt us to evaluate the Ley–Griffith TPAP (0.05 equiv.)/NMO (2 equiv.) oxidising system19 on the iodoallylic alcohol 18 in CH2Cl2 in the presence of 4 Å sieves. This reaction worked reasonably well at rt, providing the desired α-iodo-enal 20 in 54–64% yield after just 15 min. To our surprise, a much slower-moving by-product was also formed alongside 20; this is suspected to be the N-oxide based upon 1H and 13C NMR analysis. Fortunately, it could be separated from 20 by SiO2 flash chromatography. The unstable iodo-enal 20 was thereafter used quickly for a Baldwin–Lee Stille cross-coupling with Me4Sn (15 equiv.), CsF (2.5 equiv.) and CuI (0.25 equiv.) in DMF at 60 °C; a reaction that needed to be conducted in darkness. The success of this coupling (76–80% yield) was confirmed by the presence of two new allylic methyl doublets at δ 1.62 ppm (J = 1.2 Hz) and 1.61 ppm (J = 1.6 Hz) in CDCl3. Due to 20 and 4 both having near identical TLC plate mobilities after a single elution, it was necessary to follow the progress of this reaction by multi-elution TLC with 3:
1 petrol/CH2Cl2 as the eluent. The product enal 4 moved as a slightly slower single spot, when compared with the iodo-enal 20; 4 also stained dark blue when the TLC plate was heated with the anisaldehyde/H2SO4 stain. The iodo-enal 20 stained brown. It is worth noting that performing this coupling at a temperature significantly below 60 °C led to a marked diminution in the yield of 4; so 60 °C is essential and optimal.
Surprisingly the Wittig condensation of aldehyde 4 with stabilised P-ylide 5 took 6–10 d to reach completion at 38–40 °C in PhMe/CH2Cl2 (1.25:
1), and again, 4 and 3 had near identical TLC mobilities. When complete, the reaction furnished the dienoate 3 in 86–90% yield with total geometric control.
Unfortunately, the subsequent O-desilylation of 3 with n-Bu4NF in THF, or CsF in DMF, or HF/pyridine did not lead to the expected alcohol but, instead, a multitude of products. With n-Bu4NF, 4-dimethylaminobenzaldehyde (10) was observed amongst the products, confirming that a retro-vinylogous aldol cleavage occurred at C(6)/C(7). This unexpected result led to an immediate change in our synthetic planning.
Without separation, the two C(7)-diastereoisomers of ester 3 were saponified with 90–98% yield with LiOH (4 equiv.) in 1:
1
:
1 THF/MeOH/H2O. The known acid 21
17f was then oxidatively converted into (+)-trichostatic acid (22) by brief exposure to 1.5 equiv. of DDQ in 20
:
1 CH2Cl2/H2O at 0 °C for just 7 min. Such precise timing was essential to avoid extensive decomposition of the (+)-trichostatic acid 22 so formed. Although, in principle, the viability of this reaction had already been demonstrated by Hosokawa and Tatsuta in 2005,17f these workers never supplied an experimental procedure for this reaction, which meant that considerable experimentation was needed on our part to obtain a successful outcome. Nonetheless, with the new procedure reported here, the above reaction can now deliver 22 in 54–71% yield, with only a small amount of the starting material ever remaining at the reaction end.
With acid 22 in hand, it could be converted into the mixed anhydride 23 by treatment with 2 equiv. of ethyl chloroformate at 0 °C in THF.17b,e Exposure to 2 equiv. of TBSO-NH2 according to Helquist's procedure17e thereafter afforded 24, which was deprotected with CsF in MeOH to obtain (+)-(R)-trichostatin A (1) in 40–60% yield over 2 steps, without loss of chirality.17 The latter was proven by our synthetic conversion of 2220 into its naturally-occurring β-glucoside, (+)-trichostatin C (1b) (NMR data in the ESI‡), which also, simultaneously, unambiguously confirmed the assigned structure of that natural product.16,20
1H NMR of pure 16 (pure α-diastereoisomer 1) (399.9 MHz, CDCl3): δ 7.60 (m, 6H, 3J119/117Sn–1H = ca. 48.0 Hz, o-C, –SnPh3), 7.35 (m, 9H, p- and m-C
, –SnPh3), 6.78 (d, J = 8.4 Hz, 2H, H7), 6.35 (d, J = 8.7 Hz, 2H, H8), 6.43 (d, J = 10.0 Hz, 3J119Sn–1H = 173.6 Hz, 3J117Sn–1H = 153.6 Hz, 1H, H3), 4.32 (s, 2H, CH2, 3J119/117Sn–1H = 54.0 Hz, H1a,b), 4.22 (d, 1H, J = 6.8 Hz, H5), 2.92 (s, 6H, N(C
3)2), 2.47 (m, 1H, J = 6.8 Hz, H4), 1.32 (br, 1H, O
), 0.83 (s, 9H, t-Bu of OTBS), 0.56 (d, J = 6.8 Hz, C4-
), −0.09 (s, 3H, C
3Si), −0.27 (s, 3H, C
3Si) ppm. 13C NMR of 16 (pure α-diastereoisomer 1) (100.57 MHz, CDCl3): δ 149.6 (C9), 149.2 (C3, 2J119/117Sn–13C = 32.2 Hz), 139.7 (C2), 139.4 (quaternary C, –SnPh3), 137.2 (o-
, –SnPh3, 3J119/117Sn–13C = 38.2 Hz), 131.4 (C6), 128.7 (p-
, –SnPh3, 4J119/117Sn–13C = 12.1 Hz), 128.5 (m-
, –SnPh3, 3J119Sn–13C = 52.3 Hz), 127.9 (C7), 111.8 (C8), 79.3 (C5), 70.4 (C1, 2J119/117Sn–13C = 46.3 Hz), 47.4 (C4, 3J119/117Sn–13C = 38.2 Hz), 40.6 (N(
H3)2), 25.9 ((
H3)3CSi), 18.3 ((CH3)3
Si), 17.6 (C4-Me), −4.4 (
H3Si), −5.1 (
H3Si) ppm.
1H NMR of the other diastereoisomer of 16 (α-diastereoisomer 2) (399.9 MHz, CDCl3). Resonances and multiplicities have been reported, where determinable, from the purified but diastereomerically enriched 3:
1 mixture of C5 epimers: δ 7.61 (m, 6H, o-C
, –SnPh3, 3J119/117Sn–1H = 48.4 Hz), 7.38 (m, 9H, –SnPh3), 6.44 (d, J = 8.8 Hz, 2H, H7) superimposed upon 6.42 (m, 1H, H3), 6.40 (d, J = 8.8 Hz, 2H, H8), 4.43 (d, J = 3.6 Hz, 1H, H5), 4.32 (s, 2H, H1), 2.88 (s, 6H, N(C
3)2), 2.27 (m, 1H, H4), 1.32 (br, 1H, O
), 0.91 (s, 9H, t-Bu of OTBS), 0.74 (d, J = 6.8 Hz, 3H, C4-
), −0.00 (s, 3H, C
3Si), −0.23 (s, 3H, C
3Si) ppm. 13C NMR (100.57 MHz, CDCl3) of the other diastereoisomer of 16 (α-diastereoisomer 2). Resonances and J values have been reported, where determinable, from the purified but diastereomerically enriched 3
:
1 mixture: δ 150.1 (C9), 149.2 (C3), 139.2 (Sn–
–CH, –SnPh3), 138.8 (C2), 137.1 (o-
, –SnPh3, 3J119/117Sn–13C = 38.2 Hz), 131.6 (C6), 128.9 (p-
, –SnPh3, 4J119/117Sn–13C = 12.1 Hz), 128.6 (m-
, –SnPh3, 4J119/117Sn–13C = 52.3 Hz), 126.8 (C7), 111.7 (C8), 77.1 (C5), 70.3 (C1, 2J119/117Sn–13C = 46.3 Hz), 47.12 (CH-Me), 40.7 (N(
H3)2), 25.9 ((
H3)3CSi), 18.3 ((CH3)3
Si), 13.8 (CH–
H3), −4.5 (
H3Si), −5.0 (
H3Si) ppm.
TOF ES+ HRMS of 16: calcd for C38H50NO2SiSn [M + H]+: 700.2640. Found: 700.2611.
Data for pure 18: 1H NMR of 18 (pure isomer 1) (399.9 MHz, CDCl3): δ 7.16 (d, J = 8.6 Hz, 2H, H7), 6.68 (d, J = 8.6 Hz, 2H, H8), 5.81 (d, J = 8.9 Hz, 1H, H3), 4.64 (d, 1H, J = 4.2 Hz, H5), 4.19 (s, 2H, H1a,b), 2.94 (s, 6H, N(C3)2), 2.65 (m, 1H, H4), 1.79 (br, 1H, O
), 0.94 (d, J = 7.0 Hz, 3H, C4-Me), 0.90 (s, 9H, t-
of OTBS), 0.02 (s, 3H, C
3Si), −0.20 (s, 3H, C
3Si) ppm. 13C NMR of 18 (pure isomer 1) (100.57 MHz, CDCl3): δ 149.8 (C9), 139.4 (C3), 130.9 (C6), 127.6 (C7), 111.9 (C8), 107.8 (C2), 76.8 (
H-OTBS), 71.9 (C1), 49.3 (C4), 40.7 (N(
H3)2), 25.8 ((
H3)3CSi), 18.2 ((CH3)3
Si), 15.3 (C4-Me), −4.5 (
H3Si), −5.0 (
H3Si) ppm.
1H NMR of 18 (isomer 2) (399.9 MHz, CDCl3). Resonances and J values have been reported, where determinable, from the purified but diastereomerically enriched 3:
1 mixture: δ 7.10 (d, J = 8.8 Hz, 2H, H7), 6.66 (d, J = 8.0 Hz, 2H, H8), 5.72 (d, J = 8.8 Hz, 1H, H3), 4.49 (d, 1H, J = 6.0 Hz, H5), 4.19 (s, 2H, H1), 2.94 (s, 6H, N(C
3)2), 2.74 (m, 1H, H4), 1.58 (br, 1H, O
), 0.89 (d, J = 6.8 Hz, 3H, C4-
), 0.87 (s, 9H, t-
of OTBS), −0.02 (s, 3H, C
3Si), −0.20 (s, 3H, C
3Si) ppm. 13C NMR of 18 (isomer 2) (100.57 MHz, CDCl3): δ 149.8 (C9), 139.4 (C3), 130.9 (C6), 127.6 (C7), 111.9 (C8), 107.7 (C2), 77.5 (C5), 71.9 (C1), 49.3 (C4), 40.7 (N(
H3)2), 25.9 ((
H3)3CSi), 18.2 ((CH3)3
Si), 15.3 (C4-
), −4.5 (
H3Si), −5.0 (
H3Si) ppm.
TOF ES+ HRMS for 18: calcd for C20H35NO2ISi [M + H]+: 476.1482. Found: 476.1500.
Data for pure 19: 1H NMR of 19 (pure isomer 1) (600.13 MHz, CDCl3): δ 7.09 (d, J = 8.4 Hz, 2H, H7), 6.66 (d, J = 7.8 Hz, 2H, H8), 5.26 (ddd, J = 9.6 Hz, 1H, H3), 4.35 (d, J = 6.0 Hz, 1H, H5), 3.98 (s, 2H, H1a,b), 2.93 (s, 6H, N(C3)2), 2.616 (m, 1H, H4), 1.557 (d, J = 1.2 Hz, C2-
), 1.25 (br s, 1H, OH), 0.85 (s, 9H, t-
of OTBS), 0.82 (d, J = 6.6 Hz, 3H C4-Me), −0.02 (s, 3H, C
3Si), −0.22 (s, 3H, C
3Si) ppm. 13C NMR of 19 (pure isomer 1) (150.92 MHz, CDCl3): δ C9 not detected, 134.5 (C3), 129.9 (C6), 127.6 (C7 and C2), 111.9 (C8), 78.9 (C5), 69.4 (C1), 41.1 (N(
H3)2), 40.7 (C4), 25.8 ((
H3)3CSi), 18.2 ((CH3)3
Si), 17.0 (C2-
), 13.9 (C4-
), −4.5 (
H3Si), −5.0 (
H3Si) ppm.
1H NMR of 19 (pure isomer 2) (600.13 MHz, CDCl3): δ 7.09 (m, 2H, H7), 6.64 (m, 2H, H8), 5.23 (ddd, J = 10.2, 3.0, 1.2 Hz, 1H, H3), 4.35 (d, J = 6.0 Hz, 1H, H5), 3.89 (s, 2H, H1a,b), 2.92 (s, 6H, N(C3)2), 2.59 (m, J = 9.6, 6.0 Hz, 1H, H4), 1.464 (d, J = 1.2 Hz, C2-
), 1.25 (br s, 1H, OH), 0.96 (d, J = 7.2 Hz, C4-
), 0.85 (s, 9H, t-
of OTBS), −0.013 (s, 3H, C
3Si), −0.21 (s, 3H, C
3Si) ppm. 13C NMR of 19 (pure isomer 2) (150.92 MHz, CDCl3): δ 149.4 (C9), 134.2 (C3), 130.0 (C6), 127.5 (C7 and C2), 111.7 (C8), 78.7 (C5), 69.3 (C1), 41.2 (N(
H3)2), 40.7 (C4), 25.9 ((
H3)3CSi), 18.3 ((CH3)3
Si), 16.0 (C2-
), 13.8 (C4-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
Data for 20 (ca. 3:
1 mixture of isomers of tentatively assigned stereochemistry at C5): IR of the 20 mixture (neat film): 3393 (w), 2959 (s), 2929 (s), 2856 (s), 2806 (w), 1701 (s), 1615 (s), 1524 (s), 1461 (m), 1388 (s), 1355 (m), 1251 (m), 1186 (w), 1168 (m), 1080 (s), 1027 (m), 1007 (m), 944 (w), 858 (m), 838 (m), 780 (m) cm−1.
1H NMR of 20 (minor isomer 1 – anti) (399.9 MHz, CDCl3): δ 8.64 (s, 1H, H1), 7.10 (d, J = 8.4 Hz, 2H, H7), 7.09 (d, J = 9.2 Hz, 1H, H3), 6.66 (d, J = 8.4 Hz, 2H, H8), 4.61 (d, 1H, J = 6.0 Hz, H5), 3.18 (m, 1H, H4), 2.94 (s, 6H, N(C3)2), 1.02 (d, J = 6.8 Hz, 3H, C4-
), 0.86 (s, 9H, t-
of OTBS), 0.028 (s, 3H, C
3Si), −0.20 (s, 3H, C
3Si) ppm. 13C NMR of 20 (minor isomer 1 – anti) (100.57 MHz, CDCl3): δ 188.1 (C1), 165.3 (C3), 150.0 (C9), 130.1 (C6), 127.33 (C7), 112.0 (C8), 111.3 (C2), 77.6 (C5), 50.2 (C4), 40.5 (N(
H3)2), 25.79 ((
H3)3CSi), 18.1 ((CH3)3
Si), 15.2 (C4-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
1H NMR of 20 (major isomer 2 – syn) (399.9 MHz, CDCl3): δ 8.59 (s, 1H, H1), 7.16 (d, J = 8.4 Hz, 2H, H7), 7.05 (d, J = 9.6 Hz, 1H, H1), 6.68 (d, J = 8.4 Hz, 2H, H8), 4.73 (d, 1H, J = 4.4 Hz, H5), 3.12 (m, 1H, H4), 2.95 (s, 6H, N(C3)2), 1.07 (d, J = 6.8 Hz, 3H, C4-
), 0.90 (s, 9H, t-
of OTBS), −0.012 (s, 3H, C
3Si), −0.17 (s, 3H, C
3Si) ppm. 13C NMR of 20 (major isomer 2) (100.57 MHz, CDCl3): δ 188.09 (C1), 165.3 (C3), 149.9 (C9), 129.8 (C6), 127.29 (C7), 111.9 (C8), 110.4 (C2), 76.4 (C5), 49.7 (C4), 40.5 (N(
H3)2), 25.84 ((
H3)3CSi), 18.2 ((CH3)3
Si), 13.3 (C4-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
TOF ES+ HRMS of 20: calcd for C20H33NO2ISi [M + H]+: 474.1325. Found: 474.1317.
Data for 4: 1H NMR of 4 (ca. 3:
1 mixture of isomers at C5) (isomer 1 – major) (399.9 MHz, CDCl3): δ 9.40 (s, 1H, H1), 7.09 (d, J = 8.8 Hz, 2H, H7), 6.65 (d, J = 8.8 Hz, 2H, H8), 6.43 (dd, J = 10.0 Hz, 1.2 Hz, 1H, H3), 4.47 (d, 1H, J = 6.0 Hz, H5), 2.93 (br m, 1H, H4) superimposed upon 2.93 (s, 6H, N(C
3)2), 1.62 (d, J = 1.2 Hz, 3H, C2-
), 0.95 (d, J = 6.8 Hz, 3H, C4-
), 0.84 (s, 9H, t-
of OTBS), −0.011 (s, 3H, C
3Si), −0.23 (s, 3H, C
3Si) ppm. 13C NMR of 4 (isomer 1 – major) (100.57 MHz, CDCl3): δ 195.6 (C1), 158.0 (C3), 149.9 (C9), 139.1 (C2), 130.9 (C6), 127.3 (C7), 112.0 (C8), 78.6 (C5), 42.9 (C4), 40.55 (N(
H3)2), 25.75 ((
H3)3CSi), 18.1 ((CH3)3
Si), 16.5 (C4-
), 9.31 (C2-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
1H NMR of 4 (isomer 2 – minor) (399.9 MHz, CDCl3): δ 9.31 (s, 1H, H1), 7.08 (d, J = 8.8 Hz, 2H, H7), 6.63 (d, J = 8.7 Hz, 2H, H8), 6.30 (dd, J = 10.0 Hz, 1.2 Hz, 1H, H3), 4.50 (d, 1H, J = 5.6 Hz, H5), 2.93 (br m, 1H, H4) superimposed upon 2.93 (s, 6H, N(C3)2), 1.61 (d, J = 1.6 Hz, 3H, C2-Me), 1.07 (d, J = 6.4 Hz, 3H, C4-Me), 0.89 (s, 9H, t-
of OTBS), −0.04 (s, 3H, C
3Si), −0.20 (s, 3H, C
3Si) ppm. 13C NMR of 4 (isomer 2 – minor) (100.57 MHz, CDCl3): δ 195.6 (C1), 157.4 (C3), 149.8 (C9), 138.5 (C2), 130.6 (C6), 127.3 (C7), 111.8 (C8), 77.8 (C5), 42.6 (C4), 40.53 (N(
H3)2), 25.83 ((
H3)3CSi), 18.2 ((CH3)3
Si), 15.3 (C4-
), 9.3 (C2-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
TOF ES+ HRMS of 4: calcd for C21H36NO2Si [M + H]+: 362.2515. Found: 362.2517.
1H NMR of 3 (isomer 1 – minor) (399.9 MHz, CDCl3): δ 7.32 (dd, J = 15.6, 0.4 Hz, 1H, H2), 7.07 (d, J = 8.8 Hz, 2H, H9), 6.64 (d, J = 8.8 Hz, 2H, H10), 5.79 (d, 1H, J = 10.0 Hz, H5), 5.75 (d, J = 15.2 Hz, 1H, H3), 4.39 (d, J = 6.0 Hz, 1H, H7), 4.20 (m, J = 7.2 Hz, 2H, C2 of OEt), 2.93 (s, 6H, N(C
3)2), 2.76 (m, 1H, H6), 1.64 (d, J = 1.2 Hz, 3H, C4-Me), 1.30 (t, J = 7.2 Hz, 3H,
of OEt), 0.87 (d, C6-Me) 0.83 (s, 9H, t-
of OTBS), −0.03 (s, 3H, C
3Si), −0.23 (s, 3H, C
3Si) ppm. 13C NMR of 3 (isomer 1 – minor) (100.57 MHz, CDCl3): δ 167.8 (C1), 150.0 (C2), 149.8 (C11), 145.4 (C5), 132.6 (C4), 131.6 (C8), 127.5 (C9), 115.4 (C3), 111.94 (C10), 78.8 (C7), 60.1 (
H2 of OEt), 42.4 (C6), 40.6 (N(
H3)2), 25.8 ((
H3)3CSi), 18.1 ((CH3)3
Si), 16.9 (C6-
), 14.3 (
of OEt), 12.4 (C4-
), −4.6 (
H3Si), −5.1 (
H3Si) ppm.
1H NMR of 3 (isomer 2 – major) (399.9 MHz, CDCl3): δ 7.23 (d, J = 15.6, 0.4 Hz, 1H, H2), 7.06 (d, J = 8.8 Hz, 2H, H9), 6.63 (d, J = 8.4 Hz, 2H, H10), 5.71 (d, J = 15.6 Hz, 1H, H3), 5.70 (d, 1H, J = 10.0 Hz, H5), 4.41 (d, J = 6.0 Hz, 1H, H7), 4.20 (m, J = 7.2 Hz, 2H, C2 of OEt), 2.92 (s, 6H, N(C
3)2), 2.76 (m, 1H, H6), 1.60 (d, J = 1.2 Hz, 3H, C4-Me), 1.29 (t, J = 7.2 Hz, 3H,
of OEt), 1.00 (d, J = 6.8 Hz, 3H, C6-
), 0.88 (s, 9H, t-
of OTBS), −0.015 (s, 3H, C
3Si), −0.22 (s, 3H, C
3Si) ppm. 13C NMR of 3 (isomer 2 – major) (100.57 MHz, CDCl3): δ 167.7 (C1), 149.9 (C2), 149.7 (C11), 145.0 (C5), 132.1 (C4), 131.4 (C8), 127.4 (C9), 115.5 (C3), 111.9 (C10), 78.3 (C7), 60.1 (
H2 of OEt), 42.4 (C6), 40.6 (N(
H3)2), 25.9 ((
H3)3CSi), 18.2 ((CH3)3
Si), 15.9 (C6-
), 14.3 (
of OEt), 12.3 (C4-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
TOF ES+ HRMS of 3: calcd for C25H42NO3Si [M + H]+: 432.2934. Found: 432.2942.
Data for 21 (for a 3:
1 mixture of C7-epimers): IR of the 21 mixture (neat film): 3376 (extremely br), 2959 (s), 2932 (s), 2858 (m), 2806 (w), 1688 (s), 1617 (s), 1524 (s), 1468 (m), 1383 (m), 1282 (m), 1254 (m), 1209 (w), 1072 (s), 1029 (m), 987 (w), 871 (s), 777 (m) cm−1.
1H NMR of 21 (isomer 1 – minor) (399.9 MHz, CDCl3): δ 10.58 (very br, 1H, –CO2), 7.41 (d, J = 15.6 Hz, 1H, H2), 7.08 (d, 2H, H9), 6.65 (d, 2H, H10), 5.86 (d, 1H, J = 9.6 Hz, H5), 5.72 (d, J = 15.6 Hz, 1H, H3), 4.40 (d, J = 6.0 Hz, 1H, H7), 2.93 (s, 6H, N(C
3)2), 2.78 (m, 1H, H6), 1.66 (s, 3H, C4-
), 0.89 (d, 3H, C6-
obscured by a large singlet for t-Bu for the major isomer of 21), 0.84 (s, 9H, t-
of OTBS), −0.02 (s, 3H, C
3Si), −0.23 (s, 3H, C
3Si) ppm. 13C NMR of 21 (isomer 1 – minor) (100.57 MHz, CDCl3): δ 172.9 (C1), 152.3 (C2), 149.8 (C11), 146.8 (C5), 132.7 (C4), 131.6 (C8), 127.5 (C9), 114.5 (C3), 112.0 (C10), 78.8 (C7), 42.6 (C6), 40.7 (N(
H3)2), 25.8 ((
H3)3CSi), 18.1 ((CH3)3
Si), 16.9 (C6-
), 12.4 (C4-
), −4.6 (
H3Si), −5.1 (
H3Si) ppm.
1H NMR of 21 (isomer 2 – major) (399.9 MHz, CDCl3): δ 10.58 (very br, 1H, –CO2), 7.32 (d, J = 15.6 Hz, 1H, H2), 7.07 (d, J = 8.4 Hz, 2H, H9), 6.65 (d, J = 8.4 Hz, 2H, H10), 5.76 (d, 1H, J = 10.4 Hz, H5), 5.71 (d, J = 15.6 Hz, 1H, H3), 4.43 (d, J = 6.0 Hz, 1H, H7), 2.93 (s, 6H, N(C
3)2), 2.78 (m, 1H, H6), 1.62 (s, 3H, C4-Me), 1.01 (d, J = 6.8 Hz, 3H, C6-
), 0.89 (s, 9H, SiC(CH3)3), −0.01 (s, 3H, C
3 Si), −0.21 (s, 3H, C
3Si) ppm. 13C NMR of 21 (isomer 2 – major) (100.57 MHz, CDCl3): δ 172.8 (
O), 152.2 (C2), 149.7 (C11), 146.4 (C5), 132.2 (C4), 131.4 (C8), 127.4 (C9), 114.7 (C3), 112.0 (C10), 78.2 (C7), 42.5 (C6), 40.7 (N(
H3)2), 25.9 ((
H3)3CSi), 18.2 ((CH3)3
Si), 15.8 (C6-
), 12.3 (C4-
), −4.5 (
H3Si), −5.1 (
H3Si) ppm.
TOF ES+ HRMS of 21: calcd for C23H38NO3Si [M + H]+: 404.2621. Found: 404.2613.
Data for 22: [α]D = +150.7° (c 0.416, CH2Cl2), mp 89–90 °C [literature mp17 88–89 °C].
IR of 22 (neat film): 3600–2300 (extremely br), 2980 (m), 2932 (m), 2874 (m), 2669 (w), 2596 (w), 1685 (s), 1597 (s), 1552 (m), 1438 (m), 1380 (s), 1272 (m), 1244 (m), 1191 (m), 1171 (m), 1004 (w), 979 (w), 858 (w), 828 (w), 737 (m) cm−1.
1H NMR of pure 22 (400.11 MHz, CDCl3): δ 7.84 (d, J = 9.2 Hz, 2H, H9), 7.36 (d, J = 15.6 Hz, 1H, H2), 6.64 (d, J = 9.2 Hz, 2H, H10), 6.06 (d, J = 9.6 Hz, 1H, H5), 5.85 (d, 1H, J = 15.6 Hz, H3), 4.38 (m, 1H, H6), 3.05 (s, 6H, N(C3)2), 1.92 (d, J = 1.2 Hz, 3H, C4-Me), 1.31 (d, J = 6.8 Hz, 3H, C6-
) ppm. 13C NMR of 22 (100.57 MHz, CDCl3): δ 198.3 (C7), 171.7 (C1), 153.5 (C11), 151.4 (C2), 143.0 (C5), 132.6 (C4), 130.6 (C9), 123.9 (C8), 115.7 (C3), 110.8 (C10), 40.9 (C6), 40.0 (N(
H3)2), 17.7 (C6-
), 12.5 (C4-
) ppm.
TOF ES+ HRMS of 22: calcd for C17H22NO3 [M + H]+: 288.1600. Found: 288.1584.
To a stirred rt solution of the aforementioned TBS-protected crude trichostatin A 24 in dry MeOH (2 mL) under N2 was added solid CsF (35.6 mg, 0.23 mmol, 1.2 equiv.) (pre-dried at 120 °C under high vacuum for 2 h), and the reactants were allowed to stir for 1 h. The reaction mixture was then diluted with CH2Cl2 (5 mL) and washed with H2O (2 mL). The aqueous layer was then further extracted with CH2Cl2 (10 mL × 5). The combined organic extracts were washed with H2O (20 mL × 1), dried over MgSO4, filtered and concentrated under reduced pressure. The crude mixture was purified by gradient elution SiO2 flash chromatography with CH2Cl2/MeOH (25:
1 → 20
:
1) to obtain (+)-(R)-trichostatin A (1a) (35 mg, 59% over 2 steps) as a white solid.
Data for (R)-(+)-trichostatin A (1a): [α]D = +88.8° (c 0.26, MeOH), mp 140–143 °C [lit.17 140–143 °C]. IR of (+)-TSA (1a) (neat film): 3234 (br, s), 2927 (s), 2853 (s), 1650 (m), 1595 (s), 1547 (m), 1383 (s), 1249 (m), 1189 (s), 1059 (m), 976 (m) cm−1.
1H NMR of (+)-TSA (1a) (600.13 MHz, CD3OD): δ 7.87 (d, J = 9.0 Hz, 2H, H9), 7.18 (d, J = 15.0 Hz, 1H, H2), 6.72 (d, J = 9.6 Hz, 2H, H10), 5.91 (d, J = 9.6 Hz, 1H, H5), 5.87 (d, 1H, J = 15.6 Hz, H3), 4.53 (dq, J = 9.0, 6.6 Hz, 1H, H6), 3.06 (s, 6H, N(C3)2), 1.92 (s, 3H, C4-
), 1.27 (d, J = 6.6 Hz, 3H, C6-
) ppm.
13C NMR of (+)-TSA (1a) (150.92 MHz, CD3OD): δ 201.4 (C7), 166.8 (C1), 155.5 (C11), 145.9 (C2), 141.3 (C5), 134.3 (C8), 131.9 (C9), 124.7 (C4), 117.1 (C3), 111.9 (C10), 41.7 (C6), 40.1 (N(H3)2), 18.3 (C6-
), 12.7 (C4-Me) ppm.
TOF ES+ HRMS of (+)-TSA (1a): [M + H]+ calcd for C17H23N2O3: 303.171. Found: 303.177.
Footnotes |
† Dedicated with admiration and respect to the memory of the great Professor Amos B. Smith III (2014 William H. Nichols Gold Medallist, 2015 RSC Perkin Prize Winner, 2009 RSC Simonsen Medallist, and 2002 RSC Centenary Prize Medallist) in recognition of his numerous magnificent achievements in complex natural product total synthesis, new synthetic methodology development, materials science, and his rational design of a totally new class of HIV-1-neutralising drugs. Sadly, Professor Smith passed away on the morning of Monday February 3rd, 2025, aged 80 years. His landmark contributions to the fields of organic synthesis and medicinal chemistry will continue to serve as a source of much future inspiration to us all. He will forever be missed by his many friends, former students, postdoctoral fellows, Associate Editors, and admirers within the world of organic chemistry. Professor Smith was a recipient of the Order of the Rising Sun of Japan. |
‡ Electronic supplementary information (ESI) available: experimental procedures for the synthesis of 15, copies of the NMR, IR, and HR mass spectra of all compounds, TLC photos, and additional experimental discussions. See DOI: https://doi.org/10.1039/d4ob01848f |
§ Current address: Halazar Pharma Ltd, Edgware, Middlesex, HA8 7RB, UK. |
This journal is © The Royal Society of Chemistry 2025 |